Pharma Journalist -

Seqirus announced the next major advancement in the use of cell-based technology at its state-of-the art manufacturing facility in Holly Springs, North Carolina. In an industry…
Read More...

A U.S. jury has ordered Teva Pharmaceutical Industries Ltd to pay GlaxoSmithKline Plc more than $235 million for infringing a patent covering its blood pressure drug Coreg, court…
Read More...

Smithers Avanza, a contract research organization (CRO) supporting the pharmaceutical industry, announced that it has added three additional instruments to its bioanalytical laboratory,…
Read More...

Almac Discovery and Debiopharm International announced a collaboration to pursue the development of Almac Discovery's Wee-1 kinase inhibitor program. Under the terms of the license…
Read More...

Scientists have discovered a new type of immune cell that could predict which lung cancer patients will benefit most from immunotherapy treatment, according to a Cancer Research UK…
Read More...

Innocrin Pharmaceuticals announced that it has been granted Small and Medium-Sized Enterprise (SME) status by the European Medicines Agency’s (EMA) Micro, SME office. The SME initiative…
Read More...

Nanotherapeutics announced that Peter H. Khoury, Ph.D., MBA, formerly Senior Vice President and Chief Commercial Officer, has been appointed President and Chief Executive Officer of the…
Read More...

BlackThorn Therapeutics announced that it has received a grant from the National Institute of Neurological Disorders and Stroke (NINDS) of the National Institutes of Health (NIH). The…
Read More...

NanoSphere Health Sciences announces that it has signed a Binding Merger Agreement with Corazon Gold Corp. for 100 percent acquisition of NanoSphere’s issued and outstanding shares.…
Read More...

Navidea Biopharmaceuticals announced that it has entered into an exclusive license and distribution agreement  with Sayre Therapeutics for the development and commercialization of Tc…
Read More...